LAS VEGAS, March 12 /PRNewswire-FirstCall/ -- Gamma Pharmaceuticals Inc. (OTC Bulletin Board: GMPM) announces the receipt of purchase orders for its Jugular(R) brand Energy Products from Folsom Distributing in St. Louis, Missouri. Folsom Distributing services the QuikTrip Convenience Store outlets in St. Louis and the surrounding area. QuikTrip requested Folsom Distributing to contract directly with Gamma on its behalf. Gamma has developed a series of programs to promote its branded products. Gamma estimates that its brand promotion program developed for the St. Louis Market should result in revenue of up to $850,000 in the territory over the next 12 months. Gamma's CEO Peter Cunningham commented, "Our QuikTrip relationship will significantly boost Gamma's Jugular(R) branded products in this important market. We feel QuikTrip, the premier convenience store chain in St. Louis, will drive our market share performance and overall brand profile."
Gamma Pharmaceuticals Inc. is a marketing and product formulation company. Gamma has created, registered and branded innovative product lines that include Nutritional Supplements, Personal Care Products and Over-The-Counter (OTC) pharmaceuticals. At present, Gamma manufactures in North America, and distributes in the United States and China. Gamma's products utilize its patent pending "Gel Delivery Technology(R)"; offering consumers one of the most innovative gel product lines in the market today. Gamma uses its patent pending gel delivery technology to formulate one of the industry's only full suites of gel based products. Gamma benefits from a clear consumer preference for gel product forms; offering consumers a more pleasant experience with product forms that absorb more rapidly, are more convenient and taste great. Market categories Gamma targets are growing as rapidly as 60% per year. Gamma targets consumers in the fast growing Greater China and U.S. wellness and healthcare markets. Primary channels are retail pharmacies, supermarkets, club stores and other big box outlets. Secondary channels include internet and direct selling. Gamma uses third party distributors and sells directly to retail outlets.
Forward-Looking Statements: This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks and uncertainties, and actual circumstances, events or results may differ materially from those projected in such forward-looking statements. The Company cautions readers not to place undue reliance on any forward-looking statements. The Company does not undertake, and specifically disclaims any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.
|SOURCE Gamma Pharmaceuticals Inc.|
Copyright©2009 PR Newswire.
All rights reserved